Pfizer Tops Sanofi in $14 Billion Medivation Deal

Pfizer Inc. has agreed to buy Medivation Inc. in a deal valuing the company at $14 billion, beating out Sanofi, who had been attempting to reach a takeover agreement with Medivation. Bloomberg's Asthika Goonewardene has the details on "Bloomberg ‹GO›." (Source: Bloomberg)

Rolling Stone Sale a New Beginning, Says Mediatech's Bibb
54:10 - Porter Bibb, managing partner at Mediatech Capital Partners, discusses the origins of Rolling Stone as the controlling stake in the magazine goes up for sale. He speaks with Bloomberg's Tom Keene on "Bloomberg Surveillance." (Source: Bloomberg)
  • Tony Blair Says Mix Menace, Diplomacy for N. Korea
  • Brexit Battle Expands as Johnson Teases Resignation
  • Full Show: Bloomberg Markets Middle East (09/19)